Your browser doesn't support javascript.
loading
Transdermal Electrical Neuromodulation for Anxiety and Sleep Problems in High-Functioning Autism Spectrum Disorder: Feasibility and Preliminary Findings.
Foldes, Stephen T; Jensen, Amanda R; Jacobson, Austin; Vassall, Sarah; Foldes, Emily; Guthery, Ann; Brown, Danni; Levine, Todd; Tyler, William James; Frye, Richard E.
Afiliação
  • Foldes ST; Division of Research, Barrow Neurologic Institute at Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Jensen AR; Division of Neurology, Barrow Neurologic Institute, Phoenix, AZ 85013, USA.
  • Jacobson A; School of Biological and Health Sciences, Arizona State University, Tempe, AZ 85287, USA.
  • Vassall S; Department of Child Health, University of Arizona College of Medicine Phoenix, Phoenix, AZ 85004, USA.
  • Foldes E; Section on Neurodevelopmental Disorders, Division of Neurology, Barrow Neurologic Institute at Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Guthery A; Division of Research, Barrow Neurologic Institute at Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Brown D; Division of Psychology, Vanderbilt University, Nashville, TN 37240, USA.
  • Levine T; Speech and Hearing Science, Arizona State University, Tempe, AZ 85287, USA.
  • Tyler WJ; Division of Psychiatry, Barrow Neurologic Institute at Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Frye RE; Division of Research, Barrow Neurologic Institute at Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
J Pers Med ; 11(12)2021 Dec 06.
Article em En | MEDLINE | ID: mdl-34945779
ABSTRACT

BACKGROUND:

Autism spectrum disorder (ASD) is associated with anxiety and sleep problems. We investigated transdermal electrical neuromodulation (TEN) of the cervical nerves in the neck as a safe, effective, comfortable and non-pharmacological therapy for decreasing anxiety and enhancing sleep quality in ASD.

METHODS:

In this blinded, sham-controlled study, seven adolescents and young adults with high-functioning ASD underwent five consecutive treatment days, one day of the sham followed by four days of subthreshold TEN for 20 min. Anxiety-provoking cognitive tasks were performed after the sham/TEN. Measures of autonomic nervous system activity, including saliva α-amylase and cortisol, electrodermal activity, and heart rate variability, were collected from six participants.

RESULTS:

Self-rated and caretaker-rated measures of anxiety were significantly improved with TEN treatment as compared to the sham, with effect sizes ranging from medium to large depending on the rating scale. Sleep scores from caretaker questionnaires also improved, but not significantly. Performance on two of the three anxiety-provoking cognitive tasks and heart rate variability significantly improved with TEN stimulation as compared to the sham. Four of the seven (57%) participants were responders, defined as a ≥ 30% improvement in self-reported anxiety. Salivary α-amylase decreased with more TEN sessions and decreased from the beginning to the end of the session on TEN days for responders. TEN was well-tolerated without significant adverse events.

CONCLUSIONS:

This study provides preliminary evidence that TEN is well-tolerated in individuals with ASD and can improve anxiety.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: J Pers Med Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: J Pers Med Ano de publicação: 2021 Tipo de documento: Article